ATP1A3 as a target for isolating neuron-specific extracellular vesicles from human brain and biofluids.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37713494.
- Also identified by DOI 10.1126/sciadv.adi3647 and PMC identifier 10881047.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neuron-derived extracellular vesicles (NDEVs) are potential biomarkers of neurological diseases although their reliable molecular target is not well established. Here, we demonstrate that ATPase Na<sup>+</sup>/K<sup>+</sup> transporting subunit alpha 3 (ATP1A3) is abundantly expressed in extracellular vesicles (EVs) isolated from induced human neuron, brain, cerebrospinal fluid, and plasma in comparison with the presumed NDEV markers NCAM1 and L1CAM by using super-resolution microscopy and biochemical assessments. Proteomic analysis of immunoprecipitated ATP1A3<sup>+</sup> brain-derived EVs shows higher enrichment of synaptic markers and cargo proteins relevant to Alzheimer's disease (AD) compared to NCAM1<sup>+</sup> or LICAM<sup>+</sup> EVs. Single particle analysis shows the elevated amyloid-β positivity in ATP1A3<sup>+</sup> EVs from AD plasma, providing better diagnostic prediction of AD over other plasma biomarkers. Thus, ATP1A3 is a reliable target to isolate NDEV from biofluids for diagnostic research.
Medical subject headings
- Alzheimer Disease
- Extracellular Vesicles